Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recent developments in the use of immunotherapy in non-small cell lung cancer.
Santarpia M, Giovannetti E, Rolfo C, Karachaliou N, González-Cao M, Altavilla G, Rosell R. Santarpia M, et al. Among authors: rolfo c. Expert Rev Respir Med. 2016 Jul;10(7):781-98. doi: 10.1080/17476348.2016.1182866. Epub 2016 May 13. Expert Rev Respir Med. 2016. PMID: 27148808 Review.
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.
Malapelle U, Sirera R, Jantus-Lewintre E, Reclusa P, Calabuig-Fariñas S, Blasco A, Pisapia P, Rolfo C, Camps C. Malapelle U, et al. Among authors: rolfo c. Expert Rev Mol Diagn. 2017 Mar;17(3):209-215. doi: 10.1080/14737159.2017.1288568. Epub 2017 Feb 9. Expert Rev Mol Diagn. 2017. PMID: 28129709 Review.
Immunotherapy in NSCLC: A Promising and Revolutionary Weapon.
Rolfo C, Caglevic C, Santarpia M, Araujo A, Giovannetti E, Gallardo CD, Pauwels P, Mahave M. Rolfo C, et al. Adv Exp Med Biol. 2017;995:97-125. doi: 10.1007/978-3-319-53156-4_5. Adv Exp Med Biol. 2017. PMID: 28321814 Review.
Immunotherapy in Lung Cancer: A New Age in Cancer Treatment.
Corrales L, Scilla K, Caglevic C, Miller K, Oliveira J, Rolfo C. Corrales L, et al. Among authors: rolfo c. Adv Exp Med Biol. 2018;995:65-95. doi: 10.1007/978-3-030-02505-2_3. Adv Exp Med Biol. 2018. PMID: 30539506 Review.
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
Rodríguez-Martínez A, de Miguel-Pérez D, Ortega FG, García-Puche JL, Robles-Fernández I, Exposito J, Martorell-Marugan J, Carmona-Sáez P, Garrido-Navas MDC, Rolfo C, Ilyine H, Lorente JA, Legueren M, Serrano MJ. Rodríguez-Martínez A, et al. Among authors: rolfo c. Breast Cancer Res. 2019 Feb 6;21(1):21. doi: 10.1186/s13058-019-1109-0. Breast Cancer Res. 2019. PMID: 30728048 Free PMC article.
391 results